Introduction
Nephropathic Cystinosis is a rare genetic disease, characterised by extremely high lysosomal levels of cystine, the oxidized dimer form of the amino acid cysteine and manifested by a general failure to thrive (Buchan, et al. 2012) . The accumulation of cystine as crystals in most tissues leads to the progressive impairment and dysfunction of multiple organs, such as the pancreas, eye, brain and thyroid (Syres, et al. 2009 ). Without treatment, this autosomal recessive disease can result in multi-organ failure and death before the onset of puberty (Gahl, 2009 ). The main treatment for the disorder remains the administration of the aminothiol, cysteamine (figure 1) (as the bitartrate salt, Cystagon®) (Thoene, et al. 1995) . Cysteamine therapy produces rapid depletion of cystine from leukocytes, with minor side effects (Schneider, et al. 1976; Schneider 2004) .
Corneal crystal deposition is one of the most troublesome complications affecting patients with cystinosis and persists even as their prognosis improves and life expectancy increases. Photophobia and, ultimately, blepharospasm affect the quality of life to such an extent that the slightest glimmer of sunlight can be debilitating. In addition, crystal accumulation over a period of years can cause the formation of corneal scars, keratitis and cataracts, as well as band keratopathies (Gahl et al., 2000) . The oral form of Cystagon has no effect on depleting corneal crystals due to poor drug availability stemming from the absence of vasculature in the cornea (Gahl, et al. 1987; Gahl and Kuehl, 2000) , thus cysteamine must also be administered topically in the form of eye drops.
Compliance with the use of eye drops is a major issue however, as in order to achieve the maximum benefit in their current formulation these drops must be routinely administered every hour while awake (Gahl and Kuehl, 2000; Gahl, et al. 2007 ). This is due to a low bioavailability commonly reported for topical eye treatments, with tissue contact time varying from 1-2 minutes (Gangrade, et al. 1996; Jansook, et al. 2010; Le Bourlais, et al. 1998) to 5 minutes (McKenzie and Kay 2015; Robinson, 1989; Shell, 1984; Urtti and Salminen 1993) . This short ophthalmic residence time is due to a multitude of protective mechanisms such as blinking and high tear fluid production and turnover (Ahmed and Patton, 1987; Kaur and Kanwar, 2002; Saettone and Salminen, 1995; Morrison et al 2013) . The current drops, which contain 0.55% cysteamine hydrochloride in saline also cause frequent stinging and redness upon application (Gahl 2009 ).
By formulating cysteamine as a bioadhesive ophthalmic gel with controlled drug release, it is hypothesised that administration frequency may be reduced, perhaps allowing once or twice-daily dosing instead of the current hourly requirement.
These formulation changes may reduce the burden of treatment and improve compliance, producing long-term prevention of ophthalmic morbidity, such as blindness. Hydrogels which are pseudoplastic, transparent and bioadhesive are highly desirable for topical ophthalmic application, and have the potential for less frequent application and improved patient compliance. (table 2) . This maintained the apparent viscosity of the gels within the limits tolerated by the eye. Gels which performed satisfactorily were loaded with 0.55%w/w CH and subjected to further testing: dissolution, bioadhesion, toxicity, stability and surface tension. Unmedicated gels were used as controls. Simulated Lachrymal Fluid (SLF) at pH 7.4 was used to mimic tear fluid during tests. It was also used in the production of the ophthalmic gels to provide additional buffering capacity.
Materials and methods
The following salts were weighed out and stirred in a 1 L volumetric flask: potassium chloride 0.179% w/v, sodium chloride 0.631% w/v, sodium carbonate 0.218% w/v, calcium carbonate 0.004% w/v and magnesium chloride 0.005% w/v. Hydrochloric acid (0.1M) was used to adjust the pH to 7.4. Sorensen's Modified Phosphate Buffer (SMPB) was also added to the gels to stabilise the gels at pH7.4. It is one of the most common ophthalmic buffers used. Briefly, a solution of 0.2M monosodium phosphate and disodium phosphate was made in WFI.
Rheology
The rheological properties of the gel were studied using an Advanced Rheometer AR1000 from TA Instruments (Delaware, USA). A 60 mm, 2° angle cone geometry was used, with a truncation value of 65 µm. All measurements were made at 34°C, the temperature at the corneal surface. Continuous shear measurements were made initially, using a linear mode and a continuous ramp of 0-600 s -1 , and 600-0 s -1 over 20 minutes, to establish flow types such as Newtonian or pseudoplastic.
Oscillatory measurements were performed on the gels to characterise the linear visco-elastic behaviour and relate the rheological parameters to molecular structure. A linear mode was used with a frequency of 1-10 Hz, and 20 sample points. The controlled variable was percentage strain. The sample volume was approximately 1.5 ml. All tests were performed in triplicate.
Optical transmission
The optical transmission of each gel was measured using a Cecil CE 3021
Spectrometer (Cambridge, England). The transmission was measured as a ratio of the amount of light unabsorbed by the gel to the total amount of light the gel was exposed to, expressed as a percentage. A wavelength of 480 nm was used, the middle of human light wavelength perception. The gels were measured with 1cm, 5mm and 2mm path lengths; although in situ they would be less than a millimetre thick. The gels were referenced to deionised water at room temperature, which was taken as 100% transmission. A figure greater than 90% was classed as transparent, between 10 and 90% as translucent, and less than 10% as opaque (Buchan, et al. 2010) . Each test was performed in triplicate.
Evaluation of cysteamine release via dissolution
A 100 ml round-bottomed flask was held in a water bath, heated to 34°C. To the flask 50 ml aqueous solution of SLF and Tris buffer (90:10) was added, and an equimolar quantity (to the concentration of cysteamine in the gel) of Ellman's reagent was added, and this solution was stirred magnetically using an IKA RET basic hotplate stirrer (Staufen, Germany). A dialysis membrane (12-14,000 kDa) containing 7 ml of the gel and, tied in a rod shape (length 2.23 cm; radius 1 cm, average of 3 measurements) to exclude air bubbles, was added to the flask at time zero. The quantity of gel used was chosen to avoid reaching the limit of detection of the UV spectrometer. The medium was sampled every 2 minutes for the first ten minutes, every 5 minutes for an hour, and every 15 minutes after the first hour. Samples were analysed at 440nm, the max for DTNB. Dissolution tests were performed in triplicate.
Bioadhesion
Bovine corneal tissue, which is reported as being similar in structure to the human cornea, was used as a control (Loch C, et al. 2012) . A Texture Analyser (Stable Micro Systems, Surrey, UK) was used to measure the force required to remove the gel from an area of bovine cornea (Thirawong, et al. 2007 ). Fresh bovine eyes were collected immediately after slaughter, and washed with deionised water. The whole cornea was then excised and washed in SLF at room temperature. Prior to testing, the corneas were placed on a tissue to remove excess fluid. Cyanoacrylate glue was then used to attach a cornea to a 2 cm 2 stainless steel plate. Care was taken not to allow the glue to come into contact with the upper surface of the tissue. Immediately after this, the steel plates were attached (in pairs) to the Texture Analyser, one positioned directly above the other. Each gel sample was placed between the cornea samples and held together for 60 seconds; the force required to separate the plates was then measured (contact force of 0.05 N, contact time 60 s, probe speed 0.5 mm/s). The force was plotted against distance;
the area under the curve (AUC) being equal to the work of adhesion (Wad) (Thirawong, et al. 2007; Varum, et al. 2010) . Each individual test was undertaken nine times. Statistical significance was determined using a Mann-Whitney test.
Toxicity
The effect of the gel carriers on healthy human fibroblasts was determined using an alamar Blue test (Fisher Scientific, UK).
Stability testing
A 12 week stability study was performed to elucidate the effect of storage containers and conditions on cysteamine oxidation. Storage was at 4˚C or 21˚C, under air or nitrogen, in beakers, crimped bottles or sealed glass ampoules.
Stability was quantified by measuring the cysteamine content in the gels using Ellman's reagent; cysteamine content over time was compared to 100% at the beginning of the test (T0).
Surface tension
Surface tension studies were performed using a torsion balance (Malvern Wells, UK). Tests were performed on the C934 and HA gels in triplicate at 20˚C, with and without benzalkonium chloride to ascertain the effect of the preservative on the gel.
Results
As a result of the initial literature search, eight polymers were identified as suitable candidates for ophthalmic vehicles (Table 1 ). The polymers were tested for light transmission and rheology. The polymer concentrations used initially in this project were based on published values or commercial concentrations.
As a result of the initial light transmission and rheology analysis, five gels were found to be most suitable for optical delivery: two grades of carbomer (934 and 974), xanthan gum, sodium hyaluronate and HEC. PVP and HPMC were eliminated due to unsuitable optical clarity and rheology. The carrageenan became a solid mass upon cooling, and was therefore unsuitable for use in this project. Also, PVP possessed a yellow colour which would be noticeable to the patient.
The concentrations of the five gels were adjusted to obtain a gel within the desired viscosity range, i.e. 10 mPa.s -30 mPa.s (Oechsner and Keipert, 1999; Zhu and Chauhan, 2008) (table 2) . All five gels contained cysteamine hydrochloride at a concentration of 0.55% w/v as per the current eye drop. Further analysis was performed to determine which of the five medicated gels was most suitable for ophthalmic delivery of cysteamine. Benzalkonium chloride is the most widely used preservative in ophthalmic preparations (Lewis, et al. 2007; Marple, et al. 2004 ).
More recently, the safety of this compound in the eye has been questioned, particularly in multiple-dose preparations (Baudouin, et al. 2010) . Alternatives include sodium perborate and polyquaternium 1. Polyquaternium 1 is licensed for exclusive use by Alcon pharmaceticals for use in the eye, therefore sodium perborate was tested as an alternative to benzalkonium chloride. Sodium perborate was also used as an alternative to benzalkonium choride, to determine any precipitation effect particularly for carbomer. All of the gels' parameters were unchanged except for hydroxyethyl cellulose and sodium hyaluronate which were four to five times more viscous, and carbomer 974 and xanthan gum, which were both 5-10% more optically clear. It was therefore decided to continue testing using benzalkonium chloride as a preservative.
Rheology
The rheology measurements of the gels provide information about the nature of the gel structure. All of the gels tested in Table 2 displayed a network like that of an 'entangled solution' apart from xanthan gum (Garrec and Norton 2012) .
Optical transmission
Concerns were expressed about gel opacity, particularly for carbomer 934, and as a result, optical path lengths of 2mm were also used (figure 2). It is likely that, in vivo, the gels will be much thinner, in the region of 1.5 µm (Robinson and Mlynek, 1995) . As such, the optical clarity at this thickness should be greatly improved, reducing the initial blurred vision after installation and allowing the possibility of daytime administration.
Toxicity
The effect of the gel carriers on healthy human fibroblasts was determined using the alamar Blue assay (Figure 3 ). All four of the gels tested displayed a non-toxic nature, similar to that of the control.
Stability
Long term stability tests were performed to elucidate the effect of storage containers and conditions on cysteamine oxidation. Gels were stored at four different conditions, and the percentage CH remaining over time compared. The order of oxidation stability was found to be: ampoules > crimped bottles > beakers (Table 3, Figure 5 ).
Bioadhesion
As a result of poor long-term stability, carbomer 974 and xanthan were eliminated from the study. Tests continued on the remaining three gels. Table 4 summarises the bioadhesion test results.
Dissolution
Dissolution tests using sodium hyaluronate, carbomer 934 and HEC were performed in triplicate (Figure 4) . The three gel carriers each release cysteamine over a 45-50 minute period.
Surface tension
HEC was eliminated from the study at this point. Surface tension studies were performed using a torsion balance (Malvern Wells, UK) on the final two medicated gels, sodium hyaluronate and carbomer 934. The surface tension of a liquid will
give an indication of the wetting capabilities on the corneal surface. A gel with a lower surface tension value will be able to spread more easily than a gel with a higher surface tension, and subsequent adhesion and absorption of the drug should therefore be improved (Abdelkader, et al. 2012) . As the surfactant benzalkonium chloride is used as a preservative, this should lower the surface tension further still. Tests were performed on the two gels in triplicate at room temperature (20˚C), with and without benzalkonium chloride (Table 5) .
HEC and carbomer 934 were discounted, as neither gel demonstrated comparable long-term stability to sodium hyaluronate. Therefore, the experiment and results which follow report only the sodium hyaluronate gel, at a concentration of 0.3% w/w, medicated with 0.55% w/w cysteamine hydrochloride.
Discussion
Current understanding of ocular pharmacokinetics involves mixing of the eye drops with lachrymal fluid, produced at a rate of 0.5-2.2 Lmin -1 , resulting in a short contact time with ocular tissue (Ahmed and Patton 1985; Ahmed and Patton 1987) . Subsequent drainage towards the naso-lachrymal duct during blinking results in extensive elimination of the applied solution. An ophthalmic gel may overcome these physical barriers and improve bioavailability through improved contact time with the corneal surface.
Sodium hyaluronate is a biopolymer which is found throughout the human body in tissues such as skin, cartilage and vitreous humour (Sadhasivam, et al. 2013) .
It therefore provides an inherent biocompatibility with the eye (Chung, et al. 2013 ). It also promotes wound healing, and has been used commercially in artificial tears preparations for over 30 years (Kuo, 2005) with an established safety record. It is a high-molecular weight polysaccharide (107 kDa) consisting of a backbone of alternating groups of (1-4) glucuronic acid and (1-3)-N-acetyl glucosamine (Sadhasivam, et al. 2013 ).
The physical hydrogel formed during this project was both transparent and bioadhesive and these attributes are highly desirable for topical ophthalmic application. In addition to these physico-chemical properties, the gel is isotonic due to the inclusion of SPMB buffer as an excipient, and exhibits a physiological pH of 7.4, minimising the potential for irritation.
The gels demonstrated a bioadhesive nature (p<0.01), particularly for area under the curve (AUC) (Buchan, et al. 2010) . Various theories of bioadhesion mechanisms exist, however it is widely proposed that there are two main mechanisms once the surfaces initially come into contact. Physical bioadhesion likely occurs when the polymer chains become physically entangled with natural glycoproteins on the surface of the tissue. This physical interaction can be further strengthened with chemical bonding, the type of which is dependent on the polymer's sub-groups (Thirawong, et al. 2007 ). The force required to remove the physical entanglements is measured as the AUC, while the force required to separate the probe and the plate measures the secondary chemical interactions.
Bioadhesion is a useful property in an ophthalmic treatment, particularly for a chronic condition. By holding the active compound at the site of action for a prolonged period, the frequency which the eye drop needs to be administered may be reduced.
It has been hypothesised that a viscosity of 12-15 mPa.s is optimal for ophthalmic delivery, demonstrated through in vivo work with rabbits (Rupenthal, et al. 2011) .
A viscosity of around 20 mPa.s is known to be acceptable to patients, and preparations for ophthalmic instillation such as eye gels should ideally be less than 30 mPa.s to maximise patient comfort. The sodium hyaluronate gel possessed a viscosity of 14 mPa.s, which is within the acceptable range. The gels also demonstrated pseudoplastic flow, which is ideal for ophthalmic vehicles as it permits blinking without running out of the eye (Buchan, et al. 2010) .
Dissolution tests using sodium hyaluronate, carbomer 934 and HEC were performed in triplicate (Figure 3) . The three gel carriers each release cysteamine over a 45-50 minute period. This extended release, in combination with the bioadhesive nature of the gel, may increase bioavailability compared to the current eye drop. This may permit a reduction from the multiple dosing regimen currently experienced.
Long term stability tests were performed to elucidate the effect of storage containers and conditions on cysteamine oxidation. The order of oxidation stability was found to be: ampoules > crimped bottles > beakers (Table 3, Figure 5 ). Some samples displayed a 65% improvement in stability over six weeks. Historically, cysteamine preparations have been unstable at room temperature, and have been frozen to prolong shelf life (Bozdag, et al. 2008 ). Many attempts have been made to overcome these stability issues, such as using prodrugs (Cairns, et al. 2008; Cairns, et al. 2008 ) and reformulation (Buchan, et al. 2012) , however in this project cysteamine stability was improved through chemical synthesis and storage under nitrogen, and restriction to air.
It has been reported that both carbomer 934 and hyaluronic acid possess antioxidative properties, and reduce the cell damage that would otherwise have been caused by benzalkonium chloride (Baudouin, et al. 2010 ). In addition, sodium hyaluronate is used commercially in dry eye preparations (Table 1) , and therefore will have a dual-action effect.
The surface tensions of the two gels sodium hyaluronate and carbomer 934 are similar, and both gels demonstrate a large reduction in surface tension with the addition of benzalkonium chloride (table 5) . This will be a useful property in an ophthalmic formulation, and may facilitate drug absorption into the cornea. In addition, benzalkonium chloride has a penetration enhancing effect due to corneal epithelial disruption, which can further promotes drug absorption (Abdelkader, et al. 2012 ). The analysis was performed at room temperature due to the logistics of encapsulating the entire texture analyser in a heated environment. Due to the limitations of the use of 'room temperature' it would be worth investigating the effect of temperature on this parameter.
Conclusions
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